Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances

A competitive multiple award, Indefinite Delivery/Indefinite Quantity (ID/IQ) type contract was awarded, with a ordering period (August 4, 2026 through May 14, 2031). It is anticipated that Task Orders issued against these contracts will most likely be cost-reimbursement, term/completion type Task Orders. Upon analysis of the type of work and all associated costs involved, fixed-price type task orders are usually not feasible due to the absence of precise specifications and difficulties in estimating costs with accuracy. Based upon the uncertainties involved, the Government would assume undue risk in attempting to fit relatively dynamic (science responsive and result-drive) requirement into a .... Read More

The scope of this requirement is Chemistry, Manufacturing, and Control (CMC) services for drug substances. The objective of these support services is to ensure receipt of Drug Substances (DS) of sufficient quality and quantity to support preclinical and IND-enabling studies.

The scope of this requirement is Chemistry, Manufacturing, and Control (CMC) services for drug substances. The objective of these support services is to ensure receipt of Drug Substances (DS) of sufficient quality and quantity to support preclinical and IND-enabling studies.